Communicable Disease Investigation Reference Manual

Table of Contents

1.0  Introduction

(Revised 8/13)

2.0  Map - Districts for Statewide Disease Investigation/Terrorism Response/TB Control

(Updated 3/15)

3.0  Communicable Disease Surveillance

(Updated 12/14)

4.0  Diseases or Conditions

    Anaplasmosis

(4/08)

    Animal Bites / Injuries

(7/03)

    Anthrax

(Revised 2/11)

    Arboviral Diseases, Neuroinvasive and Non-Neuroinvasive

(New 4/15)

        California Serogroup Viruses, including La Crosse Virus

        Chikungunya Virus

        Eastern Equine Encephalitis Virus

        Powassan Virus

        St. Louis Encephalitis Virus

        Venezuelan Equine Encephalitis Virus

        West Nile

        Western Equine Encephalitis

    Botulism

(Revised 12/13)

    Brucellosis

(Revised 10/13)

    Campylobacteriosis

(Revised 3/15)

    Chancroid

(7/03)

    Chlamydia Trachomatis

(7/03)

    Cholera

(Updated 4/12)

    Coccidioidomycosis

(Revised 1/12)

    Creutzfeldt-Jakob Disease

(Revised 5/05)

    Cryptosporidiosis

(Revised 8/11)

    Cyclosporiasis

(Revised 10/11)

    Dengue

(Revised 1/15)

    Diphtheria

(Updated 3/12)

    Escherichia coli O157:H7/Other Hemorrhagic E. coli

(Revised 6/11)

    Ehrlichiosis

(Revised 4/08)

    Giardiasis

(Revised 2/14)

    Glanders

(Updated 3/12)

    Gonorrhea

(7/03)

    Haemophilus influenzae, Invasive

(Revised 1/15)

    Hansen's Disease (Leprosy)

(Revised 4/12)

    Hantavirus Pulmonary Syndrome

(Updated 7/03)

    Hemolytic Uremic Syndrome (HUS), post-diarrheal

(Revised 6/11)

    Hemorrhagic Fevers (Viral)

(Revised 8/14)

         Arenaviridae: South American Hemorrhagic Viral Fevers (New World Arenaviruses)

         Arenaviridae: Lassa Fever (Old World Arenavirus)

         Bunyaviridae: Crimean-Congo Hemorrhagic Fever

         Filoviridae: Ebola Hemorrhagic Fever

         Filoviridae: Marburg Hemorrhagic Fever

    Hepatitis A

(Revised 11/13)

    Hepatitis B, acute/Delta Hepatitis

(Revised 7/08)

    Hepatitis C

(Revised 6/08)

    HIV/AIDS

(7/03)

    Influenza

(Updated 9/09)

    Latent Tuberculosis Infection

(Revised 3/14)

    Legionellosis

(Revised 12/13)

    Leptospirosis

(Updated 7/03)

    Listeriosis

(Updated 1/14)

    Lyme-like Disease

(Revised 5/08)

    Malaria

(Revised 3/14)

    Measles

(Updated 8/13)

    Meningococcal Disease

(Revised 1/15)

    Methicillin–resistant Staphylococcus aureus (MRSA)

(5/11)

    Mumps

(Revised 8/13)

    Nontuberculous Mycobacterium (NTM) / MOTT

(Revised 1/15)

    Outbreak Investigation

(Revised 7/14)

    Other Sexually Transmitted Diseases

(7/03)

          Nongonococcal Urethritis

          Mucopurulent Cervicitis

          Bacterial Vaginosis

          Trichomonal Vaginosis

          Vulvovaginal Candidiasis

          Genital Herpes

          Lymphogranuloma Venereum

          Molluscum Contagiousum

          Pelvic Inflammatory Disease (PID)

          Urinary Tract Infection

          Human Papillomavirus

          Acute Epididymitis

    Paragonimiasis

(2/11)

    Pertussis

(Revised 3/14)

    Plague

(Revised 9/12)

    Polio

(Updated 5/12)

    Psittacosis

(Updated 3/05)

    Q fever

(Revised 5/15)

    Rabies

 

          Rabies, animal

(Revised 1/14)

          Rabies, human

(Revised 1/14)

    Ricin

(Updated 2/13)

    Rocky Mountain Spotted Fever

(Revised 4/08)

    Rubella

(Revised 11/13)

    Salmonellosis

(Revised 3/11)

    Shiga toxin-producing E. coli (STEC) and
    Shiga toxin positive, unknown organism

(Revised 6/11)

    Shigellosis

(Revised 3/11)

    Smallpox

(Revised 11/13)

    Streptococcus Disease

        Streptococcus Disease, invasive, Group A

(Revised 6/02)

        Streptococcus pneumoniae, drug-resistant invasive disease

(Revised 12/12)

        Streptococcus pneumoniae, invasive in children <5 years  

(Revised 12/12)

        Streptococcal Toxic Shock Syndrome

(Revised 6/00)

    Syphilis

(7/03)

    T-2 Mycotoxins

(8/03)

    Tetanus

(Revised 11/13)

    Toxic Shock Syndrome

(Revised 6/02)

    Trichinellosis

(Revised 4/15)

    Tuberculosis Disease

(Revised 3/12)

    Tularemia

(Revised 4/09)

    Typhoid Fever

(Updated 7/03)

    Vaccinia, Adverse Reactions

(Revised 4/05)

    Vancomycin-Intermediate Staphylococcus aureus (VISA) and     Vancomycin-Resistant Staphylococcus aureus (VRSA)

(5/11)

    Varicella (Chickenpox)

(Revised 5/11)

    Vibriosis (non-cholera Vibrio species infections)

(11/12)

    Yellow Fever

(Updated 7/03)

    Yersiniosis

(Revised 3/12)

    Appendices

(Revised 9/10)



Key

New

Recently added manual section.

Reviewed

Section content is current.

Revised

Section content:  may include reporting guidelines, forms, and intervention recommendations.

Updated

Web links, agency names and phone numbers.